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A B S T R A C T
Mannose binding lectin (MBL) generally plays a protective role during viral infection, yet MBL-mediated com-
plement activation promotes Ross River virus (RRV)-induced inflammatory tissue destruction, contributing to
arthritis and myositis. As MBL binds to carbohydrates, we hypothesized that N-linked glycans on the RRV en-
velope glycoproteins act as ligands for MBL. Using a panel of RRV mutants lacking the envelope N-linked gly-
cans, we found that MBL deposition onto infected cells was dependent on the E2 glycans. Moreover, the glycan-
deficient viruses exhibited reduced disease and tissue damage in a mouse model of RRV-induced myositis
compared to wild-type RRV, despite similar viral load and inflammatory infiltrates within the skeletal muscle.
Instead, the reduced disease induced by glycan-deficient viruses was linked to decreased MBL deposition and
complement activation within inflamed tissues. These results demonstrate that the viral N-linked glycans pro-
mote MBL deposition and complement activation onto RRV-infected cells, contributing to the development of
RRV-induced myositis.
1. Importance
Mannose binding lectin (MBL), a lectin that can initiate the host
complement cascade, generally has a protective role following viral
infection. However, in the context of alphavirus-induced disease, MBL-
mediated complement activation is pathologic, promoting Ross River
virus (RRV)-induced inflammatory tissue destruction within the mus-
culoskeletal system. MBL binds to glycosylated proteins, thus we hy-
pothesized that the RRV envelope N-linked glycans promote MBL
binding, complement activation, and disease. Using a panel of mutant
viruses lacking one or more envelope glycans, we found that the RRV
E2 glycans are required for MBL binding to infected cells and sub-
sequent disease. Mice infected with a virus lacking both E2 glycans
exhibited reduced disease and tissue damage, and decreased MBL
binding and complement activation compared to mice infected with the
wild type virus. These results suggest that interactions between MBL
and the viral N-linked glycans play a major role in development of al-
phavirus-induced inflammatory disease.
2. Introduction
Arthritogenic alphaviruses such as Ross River virus (RRV) and chi-
kungunya virus (CHIKV) are mosquito-borne viruses that cause out-
breaks of infectious arthritis and myositis in many regions of the world.
Both RRV and CHIKV share similar disease symptoms that are char-
acterized by debilitating polyarthritis and myositis that frequently re-
sults in myalgia and arthralgia. Studies in both humans and mice have
identified a critical role for the host inflammatory response in the de-
velopment of disease and immunopathology following infection, with
macrophages playing an essential role in damage to the musculoskeletal
system (Lidbury et al., 2000; Morrison et al., 2006; Herrero et al., 2013,
2011).
We have previously demonstrated that the host complement system
initiated by mannose binding lectin (MBL) also has a critical role in
development of disease (Gunn et al., 2012). Interestingly, rather than
regulating the infiltration of macrophages and other inflammatory cells
into the musculoskeletal system, MBL-mediated complement activation
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24-day-old C57BL/6J mice were inoculated with 103 PFU of RRV in
following RRV infection contributes to disease by regulating in-
flammatory cell activation within the inflamed tissue through comple-
ment receptor 3 (CR3) (Gunn et al., 2012; Morrison et al., 2008). The 
C3 cleavage product iC3b produced following complement activation 
can bind to CR3 on inflammatory cells including macrophages and 
neutrophils to induce phagocytosis of iC3b-opsonized pathogens, and 
can also initiate cytotoxic effector programs through Syk-mediated 
outside-in signaling that leads to tissue damage in autoimmune dis-
orders (Ross, 2000; Abram and Lowell, 2009; Hirahashi et al., 2006). In 
the absence of MBL, C3, or CR3 expression of cytotoxic inflammatory 
mediators within muscle tissue are reduced in RRV-infected mice, 
correlating with reduced disease, but viral tropism and viral burden are 
unaffected (Gunn et al., 2012; Morrison et al., 2008). Importantly, 
production of the CR3 ligand iC3b is reduced in the absence of MBL 
following RRV infection (Gunn et al., 2012), suggesting that MBL-
mediated complement activation regulates production of iC3b and 
subsequent activation phenotype of CR3-bearing inflammatory cells 
present within the tissues.
MBL-mediated complement activation is initiated by the recognition 
of terminal sugars on glycosylated proteins by the carbohydrate re-
cognition domain (CRD) of MBL (reviewed in Takahashi et al., 2006). 
The alphavirus glycoproteins E1 and E2 contain three to four N-linked 
glycosylation sites that are glycosylated with N-linked glycans (Strauss 
and Strauss, 1994). During structural protein synthesis, the E2 and E1 
glycoproteins are processed through the ER and Golgi to generate ma-
ture E2-E1 heterodimers, which self-assemble into trimeric spikes at the 
plasma membrane. Alphaviruses bud from the plasma membrane and 
each budding alphavirus virion incorporates 80 glycoprotein spikes to 
make up the viral envelope. The E2 glycoprotein is prominently dis-
played on the surface of the virus and on the surface of infected cells, 
and for most alphaviruses, two of the N-linked glycans are located on 
E2. The RRV E2 N200 glycan is located on one side of the tip of the 
protruding E2 “petal” on the glycoprotein spike (E2 N200), and the E2 
N262 glycan appears to be located between the trimeric spikes (Pletnev 
et al., 2001). Thus, the RRV E2 N-linked glycans are surface exposed 
and are in a key position to interact with host proteins. The RRV E2 N-
linked glycans are glycosylated with a combination of high mannose 
(E2 N200) and complex (E2 N262) glycans when produced in mam-
malian cells (Shabman et al., 2008). Therefore, while we have pre-
viously demonstrated that MBL does not directly bind to free RRV 
virions (Gunn et al., 2012), we hypothesized that MBL might interact 
with the N-linked glycans on the RRV envelope glycoproteins when 
they are displayed on the surface of infected cells.
In this study, we used RRV mutants that lack one or both of the two 
N-linked glycosylation sites on E2 to demonstrate that the E2 N-linked 
glycans are required for MBL binding to infected cells and subsequent 
induction of virus-induced disease. While RRV-infected cells are readily 
bound by MBL, this activity was lost when the cells were infected with 
RRV lacking both N-linked glycans on the viral E2 glycoprotein. 
Furthermore, viruses lacking either E2 glycosylation site caused re-
duced RRV disease in mice, and a virus lacking both sites was further 
attenuated. Our results support a model of RRV pathogenesis wherein 
the E2 N-linked glycans promote activation of the lectin complement 
pathway by MBL, resulting in activation of CR3-bearing inflammatory 
cells and subsequent damage within inflamed tissues.
3. Materials and methods
3.1. Ethics statement
All mouse studies were performed in strict accordance with the 
recommendations in the Guide for the Care and Use of Laboratory 
Animals of the National Institutes of Health. All mouse studies were 
performed at the University of North Carolina (Animal Welfare 
Assurance #A3410-01) using protocols approved by the University of 
North Carolina Institutional Animal Care and Use Committee (IACUC;
Protocol #10–204 and 11–224). All studies were performed in a 
manner designed to minimize pain and suffering in infected animals, 
and any animal that exhibited severe disease signs was euthanized 
immediately in accordance with IACUC approved endpoints.
3.2. Viruses and cells
WT RRV is derived from the infectious clone of RRV T48 (pRR64), 
and the E2 N-linked glycan mutants were generated previously by site 
directed mutagenesis of N-linked glycosylation sites in E2 in pRR64 
(Shabman et al., 2008). The viral stocks used in this study were gen-
erated as described in (Morrison et al., 2006). Primary myoblasts were 
generated from skeletal muscle from one day-old C57BL/6J mice, and 
muscle was dissociated by type I collagenase (Worthington Biochem-
icals) and grown in DMEM supplemented with 6% FBS. To differentiate 
cells, the medium was replaced with DMEM containing 3% FBS. Baby 
hamster kidney (BHK-21) cells were cultured in MEM alpha supple-
mented with 10% FBS and L-glutamine. Human embryonic kidney 
(HEK) 293T cells were cultured in DMEM supplemented with 10% FBS.
3.3. MBL deposition onto myotubes
Differentiated myotubes (C2C12 or primary cells from C57BL/6J 
mice) were either mock-infected or infected with RRV WT or E2 DM at 
an MOI of 20. At 18 hpi, culture medium was removed and cells were 
incubated in medium containing either 10% serum from WT or MBL-
DKO mice for an additional 30 min. Cells were washed with PBS con-
taining 400 mM NaCl and harvested in lysis buffer. Cell lysates were 
analyzed by immunoblot analysis by standard techniques. Densitometry 
was performed using ImageJ (NIH), and values were normalized either 
to actin, RRV E2, or RRV capsid.
3.4. Immunofluorescence
BHK-21 cells were infected at MOI of 1 with either diluent alone 
(mock), RRV WT or E2 DM. At 12 hpi, medium was removed and cells 
were incubated in HBSS with 5 mM CaCl2 with or without 10 µg/ml 
rhMBL (R&D Systems) for 30 min. Cells were washed with PBS, fixed 
with PFA, and stained using standard techniques using the following 
antibodies: α-MBL-C (SCBT 1:50); α-RRV (ATCC 1:1000); Alexa Fluor 
488-α mouse (Invitrogen 1:1000); and Alexa Fluor 594 α-rabbit 
(Invitrogen 1:1000). Slides were mounted with ProLong Gold with 
DAPI, (Invitrogen) and imaged by fluorescence microscopy. Images 
were processed using ImageJ (NIH).
3.5. RRV antigen detection by flow cytometry
BHK-21 or HEK 293T cells were infected at an MOI of 5 with either 
diluent (mock), RRV WT, or the indicated RRV E2 mutants. At 12 hpi, 
media was removed, cells were washed with PBS, and cells were har-
vested using cell dissociation buffer (Gibco). Cells were then spun down 
and stained for extracellular RRV antigen using α-RRV (ATCC) and 
FITC-conjugated α-mouse (eBioscience). Cells were then fixed in 4%
PFA and analyzed by flow cytometry as previously described (Morrison 
et al., 2008).
3.6. Mice
All mice used in this study were maintained and bred in house at the 
University of North Carolina (UNC) in accordance with UNC 
Institutional Animal Care and Use Committee guidelines. C57BL/6J 
mice were purchased from The Jackson Laboratories (Bar Harbor, ME).
3.7. Infection of mice with RRV
diluent in the left rear footpad. Mice were weighed daily and assigned a
clinical score based on hind limb weakness and altered gait on the
following scale: 0 = no disease; 1 = mild loss of hind limb grip; 2 =
moderate loss of hind limb grip; 3 = severe loss of hind limb grip; 4 =
no hind limb grip and mild inability to right; 5 = no hind limb grip and
complete inability to right; 6 = moribund.
3.8. Viral burden analysis
At indicated times post infection mice were sacrificed, perfused with
1× PBS, and indicated tissues were dissected and removed, weighed,
and homogenized with glass beads in diluent. Viral titers within
infected tissues were determined by plaque assay on BHK-21 cells from
tissue homogenates.
3.9. Quantification of RRV genomes
Quadriceps muscle from infected mice were removed, and homo-
genized with glass beads in Trizol (Invitrogen). Total RNA was ex-
tracted and cDNA was generated from 1 µg of RNA by Superscript III
reverse transcriptase. RRV genomes were amplified using a tagged RRV
specific primer by qRT-PCR, and absolute numbers of RRV genomes
were determined using a standard curve of serial dilutions ranging from
108 to 10° copies of RRV genomes.
Fig. 1. The RRV E2 N-linked glycans contribute to MBL deposition onto infected cells. (A) C2C12 myotubes were infected with either RRV WT or E2 DM, and incubated in WT or
MBL-DKO mouse serum. Western blots of MBL-C deposition onto cells are shown (left) and viral titer (right) (B) Same as above, but primary C57BL/6 myotube cultures were infected with
either RRV WT or E2 DM. Western blots of MBL-C deposition are shown (left) and viral titer (right). (C) C2C12 myotubes were infected with either RRV WT, E2 N200Q, or E2 N262Q and
incubated with MBL-WT mouse serum and western blot of MBL-C deposition is shown. (D) Immunofluorescence of either mock (top row), RRV WT (middle row) or RRV E2 DM (bottom
row)-infected BHK-21 cells incubated with rhMBL-C at 12 hpi. (i) Individual panels from left: DIC, MBL-C (Texas Red), RRV antigen (FITC), DAPI, and merge. No MBL-C binding was
observed in cells incubated without MBL-C (data not shown). (ii) The percentage of infected cells with MBL deposition between RRV WT and E2 DM was determined by visual analysis of
four independent fields. * p<0.05 by Mann-Whitney analysis.
modulation of MBL production by the different viruses within the in-
fected cells. Interestingly, infection with the viruses lacking each glycan
individually showed comparable MBL deposition levels to RRV WT
(Fig. 1C), indicating that both N-linked glycans contribute to MBL de-
position onto RRV-infected cells. To confirm the western blot analysis
and to determine if MBL was binding to virally infected cells in a
glycan-dependent manner, we evaluated MBL deposition by fluores-
cence microscopy. BHK-21 cells were infected with either diluent alone
(mock-infected), RRV WT or RRV E2 DM, and subsequently incubated
with recombinant human MBL. Cells were washed extensively, fixed,
stained without permeabilization to only detect surface localization of
MBL and RRV structural proteins, and imaged by fluorescence micro-
scopy. As shown in Fig. 1Di, we observed enhanced deposition of MBL
onto RRV-infected cells compared to mock-infected cells. Within the
RRV WT-infected culture, we observed deposition primarily onto the
infected cells rather than onto uninfected cells (indicated by white
arrow), indicating that viral infection of the cell contributes to MBL
deposition. Levels of MBL were reduced on cells infected with E2 DM
compared to WT, despite comparable levels of RRV antigen between
WT and E2 DM infection. Furthermore, the percentage of infected cells
with MBL deposition was significantly reduced in cells infected with
RRV E2 DM compared to WT (Fig. 1Dii). These results indicate that N-
linked glycans on the E2 glycoprotein are required for MBL deposition
on infected cells. However, while images in Fig. 1Di indicate equivalent
levels of RRV antigen expression on the cell surface, western blotting
with this antibody did not efficiently detect the E2 glycoprotein in cells
infected with the E2 DM virus, which raised the possibility that the lack
of N-linked glycans on the E2 protein may lead to reduced cell surface
expression of E2 and decreased MBL binding. Therefore, we quantified
RRV glycoprotein expression on the cell surface for each of the mutant
viruses by flow cytometry. As shown in Fig. 2A and Bi, the E2 DM virus
exhibited no defect in surface glycoprotein expression in BHK-21 cells
as compared to either of the single mutant viruses, which still bind MBL
(Fig. 1c). While we did observe a slight reduction in fluorescence in-
tensity of the E2 mutants as compared to WT (Fig. 2Bii); this difference
was less than two-fold. We observed a similar pattern in HEK 293T cells
(data not shown). Therefore, it is unlikely that the reduced MBL de-
position seen with the E2 DM virus is due to an overall reduction in cell
surface glycoprotein expression. Taken together, these data support the
hypothesis that MBL recognizes and binds to the E2 N-linked glycans on
the surface of infected cells.
4.2. The RRV E2 N-linked glycans contribute to severe disease
Given that the E2 N-linked glycans contributed to MBL binding to
infected cells, and since MBL contributes to RRV-induced disease, we
hypothesized that the E2 glycans also contributed to development of
RRV-induced disease. Mice were infected with either RRV WT or the
panel of glycan mutant viruses, and mice were weighed and assigned a
clinical score as previously described (Morrison et al., 2006). Consistent
with our previous studies, RRV WT-infected mice began to develop
severe disease characterized by hind-limb dysfunction by 5 days post
infection (dpi), with peak disease severity from 7 to 10 dpi (Fig. 3A),
and had reduced weight gain compared to mock-infected mice
(Fig. 3B). Consistent with a previous report (Nelson et al., 2016), mice
infected with viruses lacking either one of the E2 glycosylation sites
(Fig. 3A E2 N200Q, left; E2 N262Q, middle) developed hind-limb
dysfunction with approximately the same kinetics as WT-infected mice,
but the peak disease severity was reduced in these mice. In addition,
these mice had reduced weight loss compared to WT-infected mice
(Fig. 3B E2 N200Q, left; E2 N262Q, middle), suggesting that each in-
dividual E2 glycan contributes to the severity of RRV-induced disease.
Interestingly, mice infected with RRV E2 DM developed a very mild
disease with little to no hind-limb dysfunction, and continued to gain
weight throughout the course of infection (Fig. 3A-B, right). Notably,
the disease in the E2 DM-infected mice was remarkably similar to the
3.10. Histological analysis, immunohistochemistry, and Evans Blue dye 
(EBD) analysis
At indicated times post infection, mice were sacrificed and perfused 
with 4% PFA. Tissues were paraffin embedded and 5 µm sections were 
generated and stained with hematoxylin and eosin to examine tissue 
pathology and inflammation or probed with a goat a-mouse C3 anti-
body (1:500 Cappel) for immunohistochemistry using the Vectastain 
ABC-AP kit (Vector Labs). To visualize tissue damage by EBD, mice 
were injected with 1% EBD as previously described (Morrison et al., 
2007), and frozen sections were generated. Sections were visualized by 
either bright field or fluorescence microscopy.
3.11. Analysis of infiltrating inflammatory cells by flow cytometry
At indicated times post infection mice were sacrificed, and both 
quadriceps muscles were removed, minced, and digested and cells were 
isolated and analyzed as previously described (Gunn et al., 2012).
3.12. Statistical analysis
Data was analyzed for statistically significant differences using ei-
ther Mann-Whitney analysis, one-way ANOVA, or t-test (p < 0.05 is 
considered significant). Statistical analyses were performed using 
GraphPad Prism 5 and the statistical programming language R 
(v.3.0.2).
4. Results
4.1. RRV E2 N-linked glycans contribute to MBL deposition onto infected 
cells
We have previously shown that MBL deposition is enhanced on cells 
following RRV infection, suggesting that some aspect of viral infection 
induces MBL binding to infected cells (Gunn et al., 2012). MBL can 
recognize terminal sugars on glycans and thus we hypothesized that the 
RRV E2 N-linked glycans mediate MBL binding to infected cells re-
sulting in complement activation. Although MBL did not directly bind 
to RRV virion particles (Gunn et al., 2012), we hypothesized that the 
viral N-linked glycans may be more accessible when the viral glyco-
proteins are displayed on the cell surface compared to the virion, al-
lowing MBL to bind the N-linked glycans on the viral glycoproteins 
located on the surface of infected cells.
To test if the RRV E2 N-linked glycans were required for MBL 
binding to infected cells, we used a previously generated panel of 
mutant viruses lacking one or both E2 glycans: RRV E2 N200Q, E2 
N262Q, and E2 N200;262Q (E2 DM) (Shabman et al., 2008). Mutant 
viruses lacking the E1 glycan demonstrated significant replication de-
ficiencies in vitro (Shabman et al., 2008), and thus we did not evaluate 
this mutant in our study. Differentiated C2C12 myotubes or primary 
murine myotubes, which are derived from skeletal muscle, were in-
fected with either wild-type RRV (RRV WT) or the glycan mutants, and 
infected cells were then incubated in medium containing serum from 
either naïve WT or MBL-DKO mice as a source of MBL. Cells were ex-
tensively washed to remove unbound MBL and free virus, and cell ly-
sates were analyzed by western blot for levels of MBL. Consistent with 
our hypothesis, we observed a decrease in MBL deposition onto RRV E2 
DM-infected C2C12 cells compared to RRV WT-infected cells, despite 
similar levels of viral replication (Fig. 1A). Similar results were ob-
served in primary myotubes (Fig. 1B). When MBL deposition was nor-
malized against either the viral capsid protein or actin (Supplementary 
Figure 1), we observed a clear reduction in MBL deposition onto RRV 
E2 DM-infected cells as compared to wild-type. We did not observe MBL 
deposition in cells incubated with MBL-DKO serum, demonstrating both 
the specificity of the MBL western blots and indicating that we were 
detecting only exogenously added MBL in the assay, rather than
disease induced in MBL-DKO and complement deficient mice (Gunn
et al., 2012; Morrison et al., 2007). Taken together, these data indicate
while each of the E2 glycans contribute to disease severity individually,
both of the E2 N-linked glycans are required for development of max-
imal disease, and suggests that the N-linked glycans have a key role in
mediating RRV pathogenesis.
4.3. RRV lacking one or both E2 N-linked glycans are attenuated for
inflammatory pathology and tissue damage within quadriceps muscle
Infiltration of inflammatory cells into the skeletal muscle is a
characteristic of RRV-induced disease, and much of the disease ob-
served following RRV infection is due to the pathology mediated by
inflammatory infiltrates (Lidbury et al., 2000; Hazelton et al., 1985;
Clarris et al., 1975; Fraser et al., 1981). To assess the role of the E2
glycans in promoting inflammatory pathology following RRV infection,
we analyzed H&E-stained quadriceps muscle sections from mice in-
fected with either RRV WT or the glycan mutants at 10 dpi. As ex-
pected, we observed severe inflammatory pathology in the quadriceps
of RRV WT-infected mice evidenced by the destruction of the fibrous
architecture of the skeletal muscle and the presence of infiltrating cells
(Fig. 3C). We observed the presence of infiltrating cells in the quad-
riceps muscle of mice infected with any of E2 glycan mutant viruses.
However, consistent with reduced disease scores and previous reports
(Nelson et al., 2016), the quadriceps muscles of mice infected with ei-
ther E2 N200Q or E2 N262Q had moderate tissue damage that was
reduced compared to WT-infected mice, as indicated by the presence of
intact muscle fibers (Fig. 3C). In contrast, mice infected with E2 DM had
intact skeletal muscle fibers with minimal tissue damage despite the
presence of infiltrating cells (Fig. 3C).
To confirm that mice infected with the RRV glycan mutants had
reduced tissue damage we administered Evans Blue dye (EBD) into ei-
ther RRV WT or glycan mutant-infected mice at 10 dpi to visualize
damaged muscle fibers within the quadriceps muscle. EBD is excluded
from healthy cells, but taken up by damaged cells and can be visualized
by fluorescent microscopy; thus, EBD+ tissues indicate tissue damage.
As shown in Fig. 3D, we observed abundant EBD positive muscle fibers
in quadriceps muscle from RRV WT-infected mice. There were fewer
EBD positive fibers observed in mice infected with either of the single
E2 glycan mutants compared to RRV WT-infected mice, consistent with
the reduced clinical scores and pathology. Furthermore, EBD-positive
muscle fibers were rare in mice infected with E2 DM, suggesting that
both viral N-linked glycans are required for maximal induction of tissue
damage.
4.4. The RRV E2 N-linked glycans contribute to complement activation in
quadriceps muscle
We have previously shown that complement activation following
RRV infection is mediated primarily through MBL (Gunn et al., 2012).
Given that we observed a decrease in MBL deposition within RRV E2
DM-infected cultures, and since the disease phenotype induced by E2
DM in WT mice was strikingly similar to the disease induced by WT
RRV in MBL-DKO mice, we hypothesized that the presence of the E2
glycans contribute to MBL deposition and complement activation in the
quadriceps muscle following infection. MBL-mediated complement ac-
tivation is initiated by the recognition of terminal sugars on glycosy-
lated proteins by the carbohydrate recognition domain of MBL, and
binding of MBL to the ligand leads to formation of a C3 convertase by
the MBL-associated serine proteases resulting in localized C3 deposition
(Ricklin et al., 2010). We infected mice with either RRV WT or E2 DM,
harvested quadriceps muscle at 7 dpi and analyzed the muscle homo-
genates by western blot for MBL-C levels. As shown in Fig. 4A, RRV WT-
infected mice had elevated levels of MBL-C in the quadriceps at 7 dpi
compared to mock-infected mice, and importantly, we observed re-
duced levels of MBL in RRV E2 DM-infected mice compared to RRV WT-
infected mice, suggesting that the RRV E2 glycans contribute to MBL
deposition within infected tissues.
To determine if the reduced levels of MBL within the quadriceps
muscle of RRV E2 DM-infected mice correlated with reduced
Fig. 2. Envelope protein expression is not di-
minished by disruption of the N-linked glycans.
(A) BHK-21 cells were infected with either RRV WT
or a RRV glycan mutant at an MOI of 5 (n = 3 per
virus). At 12 hpi, intact cells were dissociated from
the dish and stained for RRV antigen (FITC). Cells
were fixed overnight and RRV envelope expression
was measured by flow cytometry. Representative dot
plots are shown. (B) (i) The percentage of infected
cells and (ii) mean fluorescence intensity (MFI) of
RRV antigen staining in (A) were quantified. Data
representative of two independent experiments.
Error bars represent the standard deviation from the
mean. One-way ANOVA performed for determina-
tion of statistical significance. * p<0.05, **
p<0.01.
complement activation, we analyzed quadriceps muscle homogenates
from RRV WT or E2 DM-infected mice for levels of C3 cleavage pro-
ducts by western blot. Consistent with our hypothesis, we observed
reduced levels of both the alpha and beta chain of C3 in E2 DM-infected
mice compared to WT-infected mice (Fig. 4B), indicating that the E2
glycans are required for C3 deposition onto infected tissues. Im-
portantly, the levels of the C3 cleavage product and CR3 ligand iC3b
was significantly reduced in E2 DM-infected mice compared to WT-
infected mice (Fig. 4B), indicating that the RRV E2 glycans are required
for robust complement activation following infection.
As western blot analysis of C3 present in quadriceps muscle tissue
does not distinguish between C3 produced by infiltrating inflammatory
monocytes and C3 that is deposited onto infected tissues, we sought to
further confirm that the RRV E2 glycans are required for C3 deposition
onto skeletal muscle following infection by immunohistochemical
staining of C3 on skeletal muscle sections. We infected mice with either
RRV WT or E2 DM, and generated sections of the quadriceps muscle at
7 dpi. Consistent with results in Fig. 4B, we observed a reduction in C3
deposition onto the skeletal muscle from mice infected with RRV E2 DM
compared to WT (Fig. 4C). Interestingly, we also observed reduced C3
deposition onto quadriceps muscle sections from mice infected with
RRV E2 N200Q or E2 N262Q compared to RRV WT (Fig. 4D). The level
of C3 deposition correlates with disease severity and is consistent with
the role of complement in determining disease severity. As the E2
glycans were required for production of iC3b, we analyzed the ex-
pression of MBL, C3, and CR3-dependent pro-inflammatory mediators
by real-time PCR to determine if their expression was also dependent on
the E2 glycans. Indeed, mice infected with RRV E2 DM had reduced
expression of MBL and C3-dependent pro-inflammatory genes com-
pared to RRV WT (Fig. 4E), further supporting the hypothesis that the
E2 N-linked glycans mediate complement activation following infec-
tion.
Fig. 3. The RRV E2 N-linked glycans contribute to severe disease. (A-C) Twenty-four day old C57BL/6 were either mock-infected, or infected with either RRV WT or a RRV glycan
mutant. Mice were assigned a clinical score (A) or weight loss (B) as described in the Experimental Procedures. Mice infected with RRV WT (solid circles) were compared directly to mice
infected with E2 N200Q (open circle, left graph), E2 N262Q (open circle, middle graph) or E2 DM (open circle, right graph). Each data point represents the arithmetic mean± SD and is
representative of at least three independent experiments. (C) Tissue pathology and inflammation was examined at 10 dpi by H&E staining of quadriceps muscle sections. A representative
section from mice infected with each virus strain is shown. (D) To assess damage within the muscle, mice infected with either RRV WT or the RRV glycan mutants were injected with EBD
at 10 dpi, and frozen sections were generated. EBD positive muscle fibers were identified by fluorescence microscopy. Representative sections of each virus strain are shown.
4.5. RRV glycan mutants retain the ability to replicate in vivo
Although the RRV E2 N-linked glycans are dispensable for replica-
tion in cell culture (Shabman et al., 2008), it is possible that the glycans
might be required for efficient viral replication and dissemination in
vivo. Therefore, we evaluated the viral titer within the quadriceps
muscle and the ankle joints from either RRV WT, or glycan mutant-
infected mice at multiple times post-infection by plaque assay. There
was no difference in viral titer within the quadriceps and ankle joints at
1 dpi between any of the viruses, suggesting that the E2 glycans are not
required for initial dissemination and replication within target tissues
(Fig. 5A-B). Overall, all of the glycan mutant viruses replicated at or
near wild-type levels in target tissues, although there were some dif-
ferences in titer observed at intermediate time points. At 3 dpi, we
observed reduced viral titer within the quadriceps muscle in mice in-
fected with E2 N200Q and E2 DM compared to WT (Fig. 5A). The E2
N262Q virus did not show any difference in titer compared to RRV WT
at any time post-infection in either the ankle or the quadriceps muscle.
Fig. 4. The RRV E2 N-linked glycans contribute to complement activation in quadriceps muscle. (A) Top, Quadriceps muscle homogenates from mock-infected mice or mice
infected with either RRV WT or E2 DM were analyzed by western blot analysis at 7 dpi to determine relative levels of MBL. Each lane represents an individual mouse. Bottom,
Normalization of MBL deposition to actin by densitometry analysis. (B) To determine if complement activation differed between mice infected with RRV WT or E2 DM, we analyzed
homogenized quadriceps muscles from either mock-infected or infected mice at 7 dpi by western blot using α-mouse C3 or α-mouse actin antibody. C3 cleavage products are indicated
with solid arrowheads. Each lane represents an individual mouse. (C, D) C3 deposition was assessed by immunohistochemistry using an α-mouse C3 antibody on quadriceps muscle
sections from mock-infected mice or mice infected with either RRV WT (C, D), E2 DM (C), E2 N200Q (D), or E2 N262Q (D) at 7 dpi. C3 positive areas are stained in blue. A representative
section from each strain is shown. (E) Relative mRNA expression of C3-dependent inflammatory mediators and cytokines S100A9, S100A8, Arginase I, and IL-6 from quadriceps muscle
from mice infected with either RRV WT (solid bar, n = 7) or E2 DM (open bar, n = 8) mice by quantitative real-time RT-PCR. Raw data values were normalized to 18S rRNA levels, and
are graphically depicted as fold expression over mock-infected mice. Data from a single experiment is shown, but is representative of two independent experiments. *** p<0.001; **
p<0.005 * p<0.05 by Student's t-test.
At 5 dpi, only the RRV E2 DM titer is reduced in the quadriceps muscle
compared to RRV WT, but importantly, at time points of severe disease,
7 and 10 dpi, no difference was observed in the quadriceps muscle
between any of the viruses (Fig. 5A). Similar results were observed in
the ankle joints, although there were significant differences in titer at
day 5 in the ankle joint between RRV E2 DM and RRV WT, but these
differences were not sustained at time points of peak disease severity (7
or 10 dpi) (Fig. 5B).
In order to confirm the plaque assay results, we also performed
quantitative real time RT-PCR to determine the absolute numbers of
RRV genomes per µg of RNA within the quadriceps muscle between WT
and E2 DM virus at 3 and 5 dpi. We did not observe any differences in
the number of RRV genomes between the two viruses at 3 dpi (Fig. 5C).
This suggests that the overall levels of viral replication within the tis-
sues are equivalent between the wild type and mutant virus at this time
point. However, consistent with reduced viral titer at 5 dpi, we ob-
served a similar decrease in viral RNA at 5 dpi in the quadriceps muscle
between WT and E2 DM (Fig. 5C). Taken together, these data indicate
that the loss of the glycans does not affect the overall ability of the virus
disseminate to and replicate within target tissues, however the E2 DM
does show reduced replication at intermediate time points.
4.6. The RRV E2 glycan mutants and WT RRV induce equivalent
inflammatory responses
RRV infection induces an inflammatory response that results in in-
filtration of inflammatory cells into target tissues such as the quadriceps
muscle, subsequently leading to tissue damage (Morrison et al., 2006).
Prior studies demonstrated that even though RRV-infected C3-/- and
MBL-DKO mice were resistant to virus-induced disease, virus induced
inflammatory cell recruitment was unaffected (Gunn et al., 2012;
Morrison et al., 2007). Therefore, we evaluated the E2 glycan mutants
to determine if virus induced inflammation was similar to that observed
in C3 or MBL deficient animals by quantifying and characterizing in-
flammatory cell populations from whole quadriceps muscle of mice
infected with the RRV WT or each of the mutant viruses by flow cy-
tometry. At 10 dpi, which is a time point of peak inflammation within
tissues, we did not observe any differences in the total magnitude or the
composition of the inflammatory cell population between RRV WT and
the glycan mutants (Fig. 6). Total numbers of leukocytes in the quad-
riceps muscle were equivalent between mice in all groups (Fig. 6), in-
dicating that the E2 N-linked glycans do not affect infiltration of in-
flammatory cells into skeletal muscle. Furthermore, the numbers of
inflammatory macrophages, which are thought to drive much of the
tissue damage during RRV infection (Lidbury et al., 2000, 2008), and
other cell types including CD4+ and CD8+ T cells, NK cells, and neu-
trophils, were equivalent between RRV WT and the glycan mutants
(Fig. 6). These data suggest that loss of the E2 glycans does not sig-
nificantly affect the induction of the infiltration or composition of the
inflammatory cells into the quadriceps muscle following RRV infection.
5. Conclusions
We report herein that the RRV E2 N-linked glycans bind MBL and
contribute to activation of complement, ultimately enhancing RRV-
mediated tissue destruction. As MBL binds to carbohydrates, we hy-
pothesized that the viral N-linked glycans displayed on RRV-infected
cells act as ligands for MBL-mediated complement activation. Thus, to
determine whether the viral N-linked glycans contribute to MBL-
mediated complement activation during RRV infection, we generated a
panel of RRV mutants that lack the E2 N-linked glycans: N200Q,
N262Q, or N200;262Q (double mutant, or DM). Consistent with our
hypothesis, reduced MBL deposition was observed onto skeletal muscle
cells infected with RRV E2 DM compared to RRV wild-type, suggesting
that the viral N-linked glycans drive MBL deposition onto infected cells.
We next determined whether the E2 N-linked glycans are required for
severe disease using a mouse model of RRV-induced myositis. RRV
mutants lacking one or both glycans fail to induce severe disease in
vivo, with mice infected with the glycan mutants exhibiting sig-
nificantly reduced inflammatory pathology and tissue damage in
quadriceps muscle compared to mice infected with wild-type RRV,
despite similar viral loads within infected quadriceps muscle and ankle
joints at times of peak disease. Importantly, MBL deposition and com-
plement activation within the skeletal muscle of RRV E2 DM infected
mice was reduced compared to wild-type virus, consistent with our
hypothesis that the viral E2 glycans drive complement activation within
Fig. 5. RRV lacking E2 N-linked glycans retain ability to replicate in vivo.
Quadriceps muscle (A) and ankle joints (B) from mice infected with RRV WT (solid cir-
cles), E2 N200Q (open circles), E2 N262Q (solid squares) or E2 DM (open square) were
assayed to determine viral titer at various times post infection. Viral titer was determined
by plaque assay on BHK-21 cells. *** p<0.005 ** p<0.01 by one-way ANOVA. (C)
Quantification of total numbers of RRV RNA genomes per µg of RNA from the quadriceps
muscles of mice infected with either RRV WT (solid circles) or E2 DM (open squares). **
p<0.01 by Student's t-test.
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inflamed tissues. Because RRV infection is associated with infiltration of
inflammatory leukocytes into the quadriceps muscle, we next tested
whether the E2 N-linked glycans modulate recruitment of inflammatory
cells into the muscle. However, similar numbers of infiltrating in-
flammatory leukocytes within skeletal muscle were observed for all
viruses, suggesting that complement activation, rather than in-
flammatory cell recruitment, is differentially activated by the E2 N-
linked glycan mutants and contributes to disease. Thus, these data de-
monstrate that the RRV E2 N-linked glycans present on infected cells
contribute to severe RRV-induced disease through MBL-mediated acti-
vation of complement.
6. Discussion
Mosquito-borne alphaviruses such as RRV and CHIKV are emerging
viruses that are a significant cause of explosive outbreaks of infectious
arthralgia and myalgia in humans. The host complement system
through MBL plays a critical role in mediating development of disease
and tissue damage through activation of inflammatory cells that in-
filtrate into the muscle and joints following infection (Gunn et al., 2012;
Morrison et al., 2008, 2007). In this study, we demonstrate that the
RRV envelope N-linked glycans contribute to MBL deposition and
complement activation leading to the development of severe virus-in-
duced damage to the musculoskeletal system.
The results presented in this study demonstrate that viral N-linked
glycans promote MBL binding to RRV infected cells and that MBL de-
position and subsequent complement activation is reduced in tissues
from animals infected with E2 DM (Figs. 1 and 4). Given the central role
that MBL, complement activation, and subsequent inflammatory cell
activation through CR3 plays in the pathogenesis of RRV-induced dis-
ease, it is likely that the major mechanism of attenuation for the E2 DM
virus is through reduced MBL binding, complement activation, and
production of the CR3 ligand iC3b leading to reduced activation of
macrophage within tissues. However, given that the E2 DM virus did
show reduced levels of replication at intermediate times post infection
(Fig. 5A), we cannot rule out the possibility that at least some of the
impact on virus-induced disease with the E2 DM virus is due to tran-
sient reduction in viral load. However, it is important to point out that
the decrease in viral load at 3 and 5 dpi did not affect the recruitment of
inflammatory cells into the sites of viral replication (Fig. 6), and that
viral loads were indistinguishable at 7 dpi, which is a time when severe
disease is readily apparent with the wild type virus (Fig. 5A-B). Fur-
thermore, we and others showed that disease is reduced in mice in-
fected with either of the single glycan mutants that exhibit either no
difference in viral loads compared to RRV WT (E2 N262Q mutant) or
modest differences in viral loads (E2 N200Q mutant) (Nelson et al.,
2016), and the reduction in disease in these mice correlates with re-
duced C3 deposition within infected tissues. Thus, these data support
the hypothesis that the E2 N-linked glycans primarily affect RRV pa-
thogenesis through complement activation.
Fig. 6. The RRV E2 glycan mutants and WT RRV induce equivalent inflammation within skeletal muscle. Leukocytes were isolated from the quadriceps muscle of mice infected
with RRV WT (solid circles), E2 N200Q (open circles), E2 N262Q (solid squares) or E2 DM (open squares) mice at 10 dpi. Cells were characterized and quantified by flow cytometry using
the markers indicated on Y-axis. Total numbers of leukocytes, inflammatory macrophages and other inflammatory cell types are shown. Each data point represents a single animal, and
data presented in the figure are combined from three independent experiments.
In summary, we have demonstrated that the interaction between the
host innate immune protein MBL and the RRV E2 N-linked glycans
contribute to the pathogenesis of RRV-induced arthritis and myositis
through activation of the host complement system. Our data supports a
therapeutic strategy of specifically targeting the interaction between
the RRV E2 N-linked glycans and MBL through the use of MBL in-
hibitors in the treatment of RRV and other virus-induced inflammatory
diseases.
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Beyond activation of the complement system, the E2 N-linked gly-
cans likely modulate other aspects of the disease (both protective and 
pathologic) through differential induction of innate immune responses 
via interactions with carbohydrate binding proteins such as C-type 
lectins, and toll-like receptors (Shabman et al., 2008). In addition, while 
we have focused on the role of the E2 glycans in mediating RRV-in-
duced disease in this study, the E1 glycan was recently shown to 
modulate RRV pathogenesis, as a mutant virus lacking the E1 glycan 
(E1 N141Q) demonstrated enhanced clearance from tissues, resulting in 
reduced inflammation and pathology (Nelson et al., 2016). Interest-
ingly, the E1 N141Q mutant enhanced circulating IFNγ levels, whereas 
viruses lacking the E2 glycans did not affect IFNγ production, sug-
gesting that the E1 and E2 glycans differentially interact with the im-
mune system (Nelson et al., 2016). Future studies aimed at identifying 
and dissecting the differential interactions of the E1 and E2 glycans 
with the innate immune system may reveal novel mechanisms through 
which viral N-linked glycans modulate viral-induced inflammatory 
disease.
The interaction between MBL and viral N-linked glycans has been 
demonstrated in a number of other virus systems including HIV, SARS-
CoV, Ebola virus, and West Nile virus (Ezekowitz et al., 1989; Zhou 
et al., 2010; Ip et al., 2005; Hart et al., 2002; Fuchs et al., 2010; Ji et al., 
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the role of viral N-linked glycans in driving this pathologic process. 
Furthermore, studies with other viruses have demonstrated that the 
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that demonstrate MBL interacts with RRV-infected cells through the E2 
N-linked glycans on the surface of the infected cell rather than with the 
virion particle. First, MBL deposition onto infected cells in vitro and 
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could diminish MBL binding. Our results suggest that the viral N-linked 
glycans are essential for promoting MBL deposition onto the surface of 
infected cells. In this way, the E2 N-linked glycans contribute to pa-
thology and disease in the mammalian host.
In addition to providing new insights into the pathogenesis of al-
phavirus-induced disease, these findings suggest that targeting inter-
actions between the viral N-linked glycans and MBL may have ther-
apeutic potential for treating RRV-induced disease. Indeed, a recent 
study using a MASP competitive binding inhibitor which blocks acti-
vation of the lectin pathway resulted in abrogation of RRV-induced 
disease (Banda et al., 2014). Thus, blocking the ability of MBL to in-
teract with the viral N-linked glycans through inhibition of downstream 
proteases, such as MASP proteins, may be a viable therapeutic strategy 
that can prevent the severe pathology associated with RRV induced 
disease, while maintaining the protective aspects of the host innate 
immune response. Furthermore, given that the viral N-linked glycan 
mutants are attenuated for disease, but not replication, it may be pos-
sible to incorporate N-linked glycan mutants into live attenuated al-
phavirus vaccines for enhanced safety.
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